Viewing StudyNCT00048776



Ignite Creation Date: 2024-05-05 @ 11:26 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00048776
Status: COMPLETED
Last Update Posted: 2005-07-19
First Post: 2002-11-07

Brief Title: Safety and Efficacy of Pletal Cilostazol for the Treatment of Juvenile Primary and Secondary Raynauds Phenomenon
Sponsor: Otsuka America Pharmaceutical
Organization: Otsuka America Pharmaceutical

Conditions & Keywords Data

Conditions:
Name
Raynauds Disease
Keywords:
Name View
Secondary Raynauds View
circulatory View
vascular View
scleroderma View
lupus View
mixed connective tissue disease View